{"content":"<li class=\"n-box-item date-title\" data-end=\"1491883199\" data-start=\"1491796800\" data-txt=\"Monday, December 23, 2019\">Monday, April 10, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3256497\" data-ts=\"1491865246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GERN\" target=\"_blank\">GERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256497-geron-settling-class-action-securities-suit-for-6_25m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron settling class-action securities suit for $6.25M</a></h4><ul>   <li>Geron (<a href=\"http://seekingalpha.com/symbol/GERN\" target=\"_blank\">GERN</a> <font color='green'>+19.5%</font>) says in a <a href=\"https://seekingalpha.com/filing/3500156\" target=\"_blank\">filing</a> that it's entered into a settlement resolving a consolidated class-action securities lawsuit.</li>    <li>In exchange for dismissal with prejudice of all claims against all defendants in the matter, Geron is settling for $6.25M in cash -- $6M of which will be paid by Geron's insurers, with the company ponying up $250K and admitting no wrongdoing.</li>    <li>The class consisted of buyers of the company's stock between Dec. 10, 2012 through and including March 11, 2014.</li>    <li>The settlement heads for a fairness hearing on July 21, 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256326-geron-completes-second-internal-data-reviews-imetelstat-trials-shares-ahead-16-percent\" target=\"_blank\">Geron completes second internal data reviews for Imetelstat trials; shares ahead 16% premarket</a> (Apr. 10 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256497\" data-linked=\"Geron settling class-action securities suit for $6.25M\" data-tweet=\"$GERN - Geron settling class-action securities suit for $6.25M https://seekingalpha.com/news/3256497-geron-settling-class-action-securities-suit-for-6_25m?source=tweet\" data-url=\"https://seekingalpha.com/news/3256497-geron-settling-class-action-securities-suit-for-6_25m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>406&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256494\" data-ts=\"1491863444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USM\" target=\"_blank\">USM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256494-u-s-cellular-unveils-prepaid-unlimited-data-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Cellular unveils prepaid unlimited-data plan</a></h4><ul>   <li>U.S. Cellular (<a href=\"http://seekingalpha.com/symbol/USM\" target=\"_blank\">USM</a> <font color='green'>+1.7%</font>) has launched an \"unlimited\" data plan as a <a href=\"http://www.fiercewireless.com/wireless/u-s-cellular-adds-unlimited-plan-for-prepaid-users\" target=\"_blank\">prepaid option</a>, the next step in a slowly heating war over wireless data.</li>    <li>The new plan joins an unlimited plan that the company set up for postpaid users in February. The new plan is $70/month for prepaid, adding to existing plans of $35/month for 1 GB and $45/month for 5 GB.</li>    <li>The company's postpaid unlimited plan comes at $60/month, which drops to $40/line for four lines.</li>    <li>As is now common with the new wave of unlimited plans, the bytes are uncapped but the service comes with restrictions: only standard-definition video rather than HD, and speeds drop to 2G level as users crest 22 GB of usage in a given month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256494\" data-linked=\"U.S. Cellular unveils prepaid unlimited-data plan\" data-tweet=\"$USM - U.S. Cellular unveils prepaid unlimited-data plan https://seekingalpha.com/news/3256494-u-s-cellular-unveils-prepaid-unlimited-data-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3256494-u-s-cellular-unveils-prepaid-unlimited-data-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256493\" data-ts=\"1491863139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256493-maxwell-techplus-20-on-47m-cash-injection-from-chinese-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxwell Tech +20% on $47M cash injection from Chinese group</a></h4><ul><li>Maxwell Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a>) <font color='green'>+20.2%</font> AH after sealing a stock purchase agreement with China's SDIC Fund Management that is expected to <a href=\"https://seekingalpha.com/pr/16795600-maxwell-signs-47-million-strategic-equity-investment-agreement-chinas-sdic-fund-management-co\" target=\"_blank\">bring ~$47M into the company</a>.</li><li>The deal, which values MXWL at $6.32/share, would raise SDIC Fund's  ownership stake in the company to 19.9%.</li><li>MXWL also says it is entering a <a href=\"https://seekingalpha.com/pr/16795595-maxwell-technologies-announces-agreement-viex-capital-advisors\" target=\"_blank\">cooperation  agreement</a> with Viex Capital Advisors, including the appointment of a director selected by the P-E firm.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256493\" data-linked=\"Maxwell Tech +20% on $47M cash injection from Chinese group\" data-tweet=\"$MXWL - Maxwell Tech +20% on $47M cash injection from Chinese group https://seekingalpha.com/news/3256493-maxwell-techplus-20-on-47m-cash-injection-from-chinese-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3256493-maxwell-techplus-20-on-47m-cash-injection-from-chinese-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256492\" data-ts=\"1491861775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256492-supervalu-to-buy-distributor-unified-grocers-in-375m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu to buy distributor Unified Grocers in $375M deal</a></h4><ul><li>Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) <a href=\"https://seekingalpha.com/pr/16795659-supervalu-acquire-unified-grocers-create-one-nations-leading-grocery-wholesale-companies\" target=\"_blank\">agrees to acquire</a> west coast focused wholesale grocery and specialty         distributor Unified Grocers for ~$375M, including debt, combining two complementary organizations with ~$16B in total 2016         sales.</li><li>SVU expects the deal to be  accretive to EPS in the first full fiscal year following closing, and forecasts at least $60M in cost synergies by the end of the third year of operations after  the completion of the transaction.</li><li>SVU&nbsp;<font color='green'>+2.6%</font>&nbsp;AH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256492\" data-linked=\"Supervalu to buy distributor Unified Grocers in $375M deal\" data-tweet=\"$SVU - Supervalu to buy distributor Unified Grocers in $375M deal https://seekingalpha.com/news/3256492-supervalu-to-buy-distributor-unified-grocers-in-375m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3256492-supervalu-to-buy-distributor-unified-grocers-in-375m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256489\" data-ts=\"1491860175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256489-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SALE' title='RetailMeNot, Inc.'>SALE</a> <font color='green'>+49.0%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+2.4%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/MTSC' title='MTS Systems Corporation'>MTSC</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='red'>-1.9%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='red'>-1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256489\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SALE $AUPH $ETSY - After Hours Gainers / Losers https://seekingalpha.com/news/3256489-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3256489-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256477\" data-ts=\"1491856636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256477-cypress-semi-enters-credit-deal-to-cut-loan-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress Semi enters credit deal to cut loan margins</a></h4><ul>   <li>Cypress Semiconductor (<a href=\"http://seekingalpha.com/symbol/CY\" target=\"_blank\">CY</a> <font color='green'>+2.2%</font>) has entered an amended credit agreement that <a href=\"https://seekingalpha.com/filing/3499771\" target=\"_blank\">cuts the margin for some term loans</a> outstanding.</li>    <li>In a filing, the company notes the $100M aggregate principal worth of term loans borrowed in 2015 will bear interest either at the base rate plus a 1.75% margin, or the Eurodollar rate plus a margin of 2.75%, at Cypress' option.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256477\" data-linked=\"Cypress Semi enters credit deal to cut loan margins\" data-tweet=\"$CY - Cypress Semi enters credit deal to cut loan margins https://seekingalpha.com/news/3256477-cypress-semi-enters-credit-deal-to-cut-loan-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3256477-cypress-semi-enters-credit-deal-to-cut-loan-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256474\" data-ts=\"1491856040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256474-axovant-down-1_8-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant down 1.8% on capital raise</a></h4><ul><li>Axovant (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) is selling <a href=\"https://seekingalpha.com/pr/16795520-axovant-sciences-ltd-announces-100-million-public-offering-common-shares\" target=\"_blank\">$100M of </a>common stock, with underwriter greenshoe for another $15M. The sale comes after the regular session's&nbsp;<font color='green'>22.5% advance</font>&nbsp;on the&nbsp;<a href=\"https://seekingalpha.com/news/3256333-axovant-sciences-announces-appointment-dr-david-hung-ceo-expansion-board-directors\" target=\"_blank\">appointment to CEO</a> of former Medivation CEO David Hung.</li><li>Shares&nbsp;<font color='red'>-</font>1.8%&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3256474\" data-linked=\"Axovant down 1.8% on capital raise\" data-tweet=\"$AXON $AXON-OLD - Axovant down 1.8% on capital raise https://seekingalpha.com/news/3256474-axovant-down-1_8-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3256474-axovant-down-1_8-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256454\" data-ts=\"1491852488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256454-investors-snack-on-avon-gnc-and-vitamin-shoppe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors snack on Avon, GNC and Vitamin Shoppe</a></h4><ul> <li>GNC Holdings (<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color='green'>+7.4%</font>), Avon Products (<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+7.4%</font>) and Vitamin Shoppe (<a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a> <font color='green'>+2.4%</font>) are all solidly higher in moves that could be related to elevated levels of short interest.</li> <li>The trio sometimes take its marching cues from Herbalife, which received a <a href=\"https://seekingalpha.com/news/3256451-herbalife-short-thesis-running-empty\" target=\"_blank\">shot in the arm</a> from Pivotal earlier today.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3256454\" data-linked=\"Investors snack on Avon, GNC and Vitamin Shoppe\" data-tweet=\"$GNC $GNC $AVP - Investors snack on Avon, GNC and Vitamin Shoppe https://seekingalpha.com/news/3256454-investors-snack-on-avon-gnc-and-vitamin-shoppe?source=tweet\" data-url=\"https://seekingalpha.com/news/3256454-investors-snack-on-avon-gnc-and-vitamin-shoppe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256452\" data-ts=\"1491851211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGVC\" target=\"_blank\">NGVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256452-grocery-store-sector-jolted-jana-interest-in-whole-foods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store sector jolted by Jana interest in Whole Foods</a></h4><ul> <li>Grocery store stocks are flying off of <a href=\"https://seekingalpha.com/news/3256445-whole-foods-plus-8-percent-jana-partners-discloses-stake\" target=\"_blank\">word</a> that Jana Partners plans to pressure Whole Foods Market after taking a stake in the compay. Real estate strategy and capital allocation are reportedly on the radar of Jana.</li> <li>Gainers include Natural Grocers by Vitamin Cottage (<a href='https://seekingalpha.com/symbol/NGVC' title='Natural Grocers'>NGVC</a> <font color='green'>+3.7%</font>), Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a> <font color='green'>+3.4%</font>), Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+2.3%</font>), Sprouts Farmers Market (<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='green'>+1.7%</font>) and Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='green'>+1.4%</font>). All the grocery names broke higher after the Whole Foods news hit..</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3256452\" data-linked=\"Grocery store sector jolted by Jana interest in Whole Foods\" data-tweet=\"$NGVC $NGVC $SFS - Grocery store sector jolted by Jana interest in Whole Foods https://seekingalpha.com/news/3256452-grocery-store-sector-jolted-jana-interest-in-whole-foods?source=tweet\" data-url=\"https://seekingalpha.com/news/3256452-grocery-store-sector-jolted-jana-interest-in-whole-foods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256451\" data-ts=\"1491851102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256451-herbalife-short-thesis-running-on-empty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife short thesis &#39;running on empty&#39;</a></h4><ul><li>Taking in a viewing of \"Betting on Zero\" over the weekend, Pivotal analyst Tim Ramey calls the documentary a \"sad&nbsp;reflection on [Bill Ackman] who been&nbsp;consistently been wrong on this name.\"</li><li>All the things Ackman said would happen - that Herbalife (<a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color='green'>+1.8%</font>) would never get a Big 4 auditor, that it would never get a clean audit opinion, that the FTC would shut it all down, that HLF could never refinance it debt, that a death spiral was imminent after the FTC settlement - never happened.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3256451\" data-linked=\"Herbalife short thesis &#39;running on empty&#39;\" data-tweet=\"$HLF - Herbalife short thesis &#39;running on empty&#39; https://seekingalpha.com/news/3256451-herbalife-short-thesis-running-on-empty?source=tweet\" data-url=\"https://seekingalpha.com/news/3256451-herbalife-short-thesis-running-on-empty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>685&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256449\" data-ts=\"1491850843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256449-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+151%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ADAT' title='Authentidate Holding Corp.'>ADAT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256449\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$STRP $SITO $PLUG - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3256449-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3256449-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256445\" data-ts=\"1491850550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256445-whole-foodsplus-8-jana-partners-discloses-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whole Foods +8% as Jana Partners discloses stake</a></h4><ul><li><a href=\"https://seekingalpha.com/filing/3499389\" target=\"_blank\">Jana Partners discloses</a> an 8.3% stake in Whole Foods (WFM <font color='green'>+8.5%</font>) and says it wants to talk with management about a number of options.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256445\" data-linked=\"Whole Foods +8% as Jana Partners discloses stake\" data-tweet=\"$AMZN - Whole Foods +8% as Jana Partners discloses stake https://seekingalpha.com/news/3256445-whole-foodsplus-8-jana-partners-discloses-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3256445-whole-foodsplus-8-jana-partners-discloses-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256443\" data-ts=\"1491849798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFG\" target=\"_blank\">NFG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256443-national-fuel-gasminus-8_5-on-new-york-denial-of-pipeline-permit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Fuel Gas -8.5% on New York denial of pipeline permit</a></h4><ul>     <li>National Fuel Gas (<a href='https://seekingalpha.com/symbol/NFG' title='National Fuel Gas Co.'>NFG</a> <font color='red'>-8.5%</font>) plunges after New York's Department of Environmental Conservation <a href=\"https://seekingalpha.com/pr/16794578-new-york-state-executive-branch-agency-denies-permits-national-fuel-s-northern-access\" target=\"_blank\">rejected</a> its proposed Northern Access Pipeline between Pennsylvania to western New York.</li><li>The DEC determined the 97-mile gas supply pipeline posed too big a threat to water quality  and wildlife and denied NFG the water quality certificate  required to construct the pipeline.</li>     <li>CEO&nbsp;Ronald Tanski defends NFG's \"great record with respect to our construction practices\" and says the \"most troubling aspect of this       decision is that the NYS DEC waited literally until the 11th hour to       issue this denial,\" despite 34 months of discussions and engineering and       environmental studies at the agency's request.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3256443\" data-linked=\"National Fuel Gas -8.5% on New York denial of pipeline permit\" data-tweet=\"$NFG - National Fuel Gas -8.5% on New York denial of pipeline permit https://seekingalpha.com/news/3256443-national-fuel-gasminus-8_5-on-new-york-denial-of-pipeline-permit?source=tweet\" data-url=\"https://seekingalpha.com/news/3256443-national-fuel-gasminus-8_5-on-new-york-denial-of-pipeline-permit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256438\" data-ts=\"1491848123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256438-sunpower-says-solar-installation-starts-new-toyota-north-america-hq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunPower says solar installation starts at new Toyota North America HQ</a></h4><ul>     <li>SunPower (<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+10.7%</font>) is surging after saying it <a href=\"https://seekingalpha.com/pr/16794517-sunpower-solar-installation-underway-new-toyota-headquarters\" target=\"_blank\">started work on an 8.79 MW solar system</a> at Toyota's (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color='green'>+0.2%</font>) new North American headquarters in Plano, Tex.</li>     <li>Once complete later this year, the project will be nearly 1 MW larger than its initial plan as well as being the largest corporate office on-site solar installation in Texas among non-utility companies.</li>     <li>As a result of 14 years of partnership, SPWR solar power systems are operating at U.S. Toyota facilities in West Caldwell, N.J., Ontario, Calif., and Torrance, Calif.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256438\" data-linked=\"SunPower says solar installation starts at new Toyota North America HQ\" data-tweet=\"$SPWR $SPWR $TM - SunPower says solar installation starts at new Toyota North America HQ https://seekingalpha.com/news/3256438-sunpower-says-solar-installation-starts-new-toyota-north-america-hq?source=tweet\" data-url=\"https://seekingalpha.com/news/3256438-sunpower-says-solar-installation-starts-new-toyota-north-america-hq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256433\" data-ts=\"1491847514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256433-nvidiaminus-1_6-bmo-sees-steeper-graphics-card-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia -1.6% as BMO sees steeper graphics card decline</a></h4><ul>   <li>Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) is <font color='red'>off 1.6%</font> as BMO Capital Markets notes its manufacturer checks show graphics cards <a href=\"http://www.cnbc.com/2017/04/10/nvidia-a-top-2016-performer-drops-after-analyst-reveals-weak-graphics-card-shipment-data-in-note.html\" target=\"_blank\">dropping 16% Q/Q in calendar Q1</a>, a steeper decline than the 6% average.</li>    <li>\"We believe this represents weakness in the channel versus the super-charged growth we have seen in the past several quarters, particularly for Nvidia's graphics business,\" notes analyst Ambrish Srivastava.</li>    <li>Srivastava reiterated an Underperform rating and $85 price target, implying 14% downside from current pricing.</li>    <li>Last week, Pacific Crest downgraded shares to Underweight (with a $105.15 price target), and Canaccord Genuity lowered its price target to $125 (but with a Buy rating). Meanwhile, Citigroup (Buy) set its price target at $145, implying 47% upside.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255696-nvidia-adding-citi-says-gaming-market-concerns-misleading\" target=\"_blank\">Nvidia adding on as Citi says gaming-market concerns 'misleading'</a> (Apr. 05 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256433\" data-linked=\"Nvidia -1.6% as BMO sees steeper graphics card decline\" data-tweet=\"$NVDA - Nvidia -1.6% as BMO sees steeper graphics card decline https://seekingalpha.com/news/3256433-nvidiaminus-1_6-bmo-sees-steeper-graphics-card-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3256433-nvidiaminus-1_6-bmo-sees-steeper-graphics-card-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256427\" data-ts=\"1491846531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMN\" target=\"_blank\">HMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256427-horace-mann-down-5-after-downgrade-progressive-upgraded\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horace Mann down 5% after downgrade; Progressive upgraded</a></h4><ul><li>Downgrading Horace Mann (<a href='https://seekingalpha.com/symbol/HMN' title='Horace Mann Educators Corporation'>HMN</a> <font color='red'>-5.1%</font>) to <a href=\"https://www.streetinsider.com/Downgrades/Keefe%2C+Bruyette+%26+Woods+Downgrades+Horace+Mann+Educators+%28HMN%29+to+Underperform/12761204.html\" target=\"_blank\">Underperform from</a> Market Perform, KBW's Meyer Shields takes issues with the stock's valuation, which seems pricey even when assuming benefits from tax reform.</li><li>At the same time, <a href=\"https://www.streetinsider.com/Upgrades/Keefe%2C+Bruyette+%26+Woods+Upgrades+Progressive+Corp.+%28PGR%29+to+Outperform/12761208.html\" target=\"_blank\">he boosts</a> Progressive (<a href='https://seekingalpha.com/symbol/PGR' title='Progressive Corporation'>PGR</a> <font color='green'>+0.9%</font>) to Outperform on expected improvement in margins.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256427\" data-linked=\"Horace Mann down 5% after downgrade; Progressive upgraded\" data-tweet=\"$HMN $HMN $PGR - Horace Mann down 5% after downgrade; Progressive upgraded https://seekingalpha.com/news/3256427-horace-mann-down-5-after-downgrade-progressive-upgraded?source=tweet\" data-url=\"https://seekingalpha.com/news/3256427-horace-mann-down-5-after-downgrade-progressive-upgraded\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256423\" data-ts=\"1491845075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256423-pharma-names-on-move-on-akorn-sales-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharma names on the move on Akorn sales talks</a></h4><ul><li>Conatus Pharma (<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+2.4%</font>), Lannett (<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='green'>+10%</font>), Endo (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+1.3%</font>), Synergy (<a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+2.9%</font>), Horizon (<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='green'>+3.1%</font>), Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='green'>+1.6%</font>), and Valeant (VRX <font color='green'>+1.4%</font>) are among those with their tails in the air <a href=\"https://seekingalpha.com/news/3256253-akorn-plus-9_5-percent-fresenius-confirms-m-discussions\" target=\"_blank\">following confirmation</a> that Fresenius is in talks to buy Akorn.</li><li>The&nbsp;PowerShares Dynamic Pharmaceuticals Portfolio (<a href='https://seekingalpha.com/symbol/PJP' title='Invesco Dynamic Pharmaceuticals Portfolio ETF'>PJP</a> <font color='green'>+0.9%</font>),&nbsp;SPDR S&amp;P Pharmaceuticals (<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='green'>+0.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3256423\" data-linked=\"Pharma names on the move on Akorn sales talks\" data-tweet=\"$CNAT $CNAT $LCI - Pharma names on the move on Akorn sales talks https://seekingalpha.com/news/3256423-pharma-names-on-move-on-akorn-sales-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3256423-pharma-names-on-move-on-akorn-sales-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256418\" data-ts=\"1491843848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256418-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/FRBA' title='First Bank &#40;Nj&#41;'>FRBA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CFBK' title='Central Federal Corporation'>CFBK</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/HMN' title='Horace Mann Educators Corporation'>HMN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256418\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MFIN $FRBA $QIWI - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3256418-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3256418-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256416\" data-ts=\"1491843721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256416-piper-jaffray-survey-shows-teens-ever-plan-to-go-iphone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray survey shows more teens than ever plan to go iPhone</a></h4><ul>     <li>Piper Jaffray sees a positive data point for the iPhone 7 and 8 (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color='green'>+0.2%</font>) in a survey that shows a <a href=\"http://www.investors.com/news/more-teens-than-ever-expect-next-phone-to-be-an-iphone-piper-jaffray/\" target=\"_blank\">record 81% of teens</a> expect their next phone to be one of Apple's models.</li>     <li>That's up from last fall's 79% and the highest it's seen, Piper says. More than three-quarters of teens in the survey say they own an iPhone now.</li>     <li>The Apple Watch is having a tougher go with teens: Fitbit (<a href=\"http://seekingalpha.com/symbol/FIT\" target=\"_blank\">FIT</a> <font color='green'>+3.4%</font>) takes 71% of the vote as favorite fitness band, vs. 10% for Apple, and only about 13% of polled teens expect to buy an Apple Watch in the next six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256416\" data-linked=\"Piper Jaffray survey shows more teens than ever plan to go iPhone\" data-tweet=\"$AAPL $AAPL $FIT - Piper Jaffray survey shows more teens than ever plan to go iPhone https://seekingalpha.com/news/3256416-piper-jaffray-survey-shows-teens-ever-plan-to-go-iphone?source=tweet\" data-url=\"https://seekingalpha.com/news/3256416-piper-jaffray-survey-shows-teens-ever-plan-to-go-iphone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256415\" data-ts=\"1491843717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256415-dish-networkplus-1_4-following-and-t-strp-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network +1.4% following AT&amp;T/STRP deal</a></h4><ul><li>Dish Network (<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a> <font color='green'>+1.4%</font>) is on the move alongside Globalstar (<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='green'>+0.9%</font>) (but both well off their session highs) after AT&amp;T agreed to pay more than a&nbsp;<font color='green'>160% premium&nbsp;</font>to buy Straight Path Communications.</li><li>Like Globalstar, Dish has unused wireless spectrum.</li><li>Late last week, UFP's Stephane Mardel suggested Dish could be worth as much as $95 per share (vs. the current low $60s) to Verizon and T-Mobile. Even on a standalone basis, Dish is worth $82, says Mardel.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256352-globalstar-15-percent-wake-and-t-straight-path-deal\" target=\"_blank\">Globalstar up 15% in wake of AT&amp;T-Straight Path deal</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3256415\" data-linked=\"Dish Network +1.4% following AT&amp;T/STRP deal\" data-tweet=\"$DISH $DISH $GSAT - Dish Network +1.4% following AT&amp;T/STRP deal https://seekingalpha.com/news/3256415-dish-networkplus-1_4-following-and-t-strp-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3256415-dish-networkplus-1_4-following-and-t-strp-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256412\" data-ts=\"1491843221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256412-another-sell-sider-climbs-on-board-amazon-sharesplus-1_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another sell-sider climbs on board Amazon; shares +1.3%</a></h4><ul><li>&ldquo;Leveraging its U.S. playbook, we expect international market expansions to drive Amazon&rsquo;s long-term growth,&rdquo; says Needham's Kerry Rice, upgrading Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.3%</font>) to <a href=\"http://blogs.barrons.com/techtraderdaily/?mod=BOL_hp_blog_tt\" target=\"_blank\">Buy from Hold</a>. The $1K price target suggests nearly&nbsp;<font color='green'>12% upside</font>&nbsp;from Friday's close.</li><li>He sees the company as having several multi-billion dollar total addressable market opportunities, among them advertising, groceries, and home services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256412\" data-linked=\"Another sell-sider climbs on board Amazon; shares +1.3%\" data-tweet=\"$AMZN - Another sell-sider climbs on board Amazon; shares +1.3% https://seekingalpha.com/news/3256412-another-sell-sider-climbs-on-board-amazon-sharesplus-1_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3256412-another-sell-sider-climbs-on-board-amazon-sharesplus-1_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256410\" data-ts=\"1491842871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBR\" target=\"_blank\">KBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256410-kbr-to-get-435m-in-settlement-of-pemex-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KBR to get $435M in settlement of Pemex dispute</a></h4><ul>     <li>KBR (<a href='https://seekingalpha.com/symbol/KBR' title='KBR, Inc.'>KBR</a> <font color='green'>+4.7%</font>) says it will <a href=\"https://seekingalpha.com/pr/16794537-kbr-recovers-almost-half-billion-dollar-judgment-resolves-lengthy-commercial-dispute\" target=\"_blank\">receive $435M</a> to settle a decade-long dispute with Mexico's Pemex over payment for work in the Bay of Campeche related to the EPC 1 offshore platform construction project.</li>     <li>In 2009, KBR received an International Chamber of Commerce arbitration award covering the costs and fees it was owed for its work for Pemex.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256410\" data-linked=\"KBR to get $435M in settlement of Pemex dispute\" data-tweet=\"$KBR - KBR to get $435M in settlement of Pemex dispute https://seekingalpha.com/news/3256410-kbr-to-get-435m-in-settlement-of-pemex-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3256410-kbr-to-get-435m-in-settlement-of-pemex-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256408\" data-ts=\"1491842664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCAP\" target=\"_blank\">GCAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256408-gain-capital-lower-4_7-on-reporting-march-metrics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GAIN Capital lower 4.7% on reporting March metrics</a></h4><ul><li><a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='red'>-4.7%</font> reports retail OTC trading volume of $239.2B up 40.5% M/M, down 10.3% Y/Y.</li><li>Active OTC accounts of 136,829 up 4.3% M/M and 3.3% Y/Y.</li><li>Institutional: ECN volume of $271.7B up 22.6% from last month and 60.7% Y/Y.</li><li>Swap dealer volume of $67.4B up 9.6% M/M, gained 4.8% Y/Y.</li><li>Futures contracts of 827,296 up 40.3% M/M, up 5.7% Y/Y.</li><li>Active future contracts of 8,201 down 0.2% M/M, down 7.8% Y/Y.</li><li><a href=\"https://seekingalpha.com/filing/3499033\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3256408\" data-linked=\"GAIN Capital lower 4.7% on reporting March metrics\" data-tweet=\"$GCAP - GAIN Capital lower 4.7% on reporting March metrics https://seekingalpha.com/news/3256408-gain-capital-lower-4_7-on-reporting-march-metrics?source=tweet\" data-url=\"https://seekingalpha.com/news/3256408-gain-capital-lower-4_7-on-reporting-march-metrics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256407\" data-ts=\"1491842497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256407-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+147%</font>. <a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+28%</font>. SWFT <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/EVRI' title='Everi Holdings Inc.'>EVRI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BEAT' title='BioTelemetry, Inc.'>BEAT</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SSKN' title='STRATA Skin Sciences, Inc'>SSKN</a> <font color='red'>-14%</font>. CLNT <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256407\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$STRP $PSTV $AXON-OLD - Midday Gainers / Losers https://seekingalpha.com/news/3256407-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3256407-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256402\" data-ts=\"1491840554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256402-rent-center-surges-5-activist-investor-picks-up-ally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center surges 5% as activist investor picks up an ally</a></h4><ul><li>An owner of 4.9% of the company, Marcato Capital <a href=\"https://seekingalpha.com/pr/16795286-marcato-sends-letter-rent-center-board-directors\" target=\"_blank\">urges the</a> Rent-A-Center (<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+5%</font>) board to immediately get started on a review of all strategic alternatives, including a possible sale.</li><li>If no action is taken, Marcato says it will throw its support behind Engaged Capital's board slate at the upcoming annual meeting.</li><li>Marcato's letter comes after the <a href=\"https://seekingalpha.com/news/3256309-rent-center-makes-speese-permanent-ceo-details-new-strategy-targets\" target=\"_blank\">company today announced</a> co-founder, Chairman, and interim CEO Mark Speese as permanent CEO, and a new strategic plan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256402\" data-linked=\"Rent-A-Center surges 5% as activist investor picks up an ally\" data-tweet=\"$RCII - Rent-A-Center surges 5% as activist investor picks up an ally https://seekingalpha.com/news/3256402-rent-center-surges-5-activist-investor-picks-up-ally?source=tweet\" data-url=\"https://seekingalpha.com/news/3256402-rent-center-surges-5-activist-investor-picks-up-ally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256401\" data-ts=\"1491840084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256401-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256401\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBIX-OLD $NTZ $NAKD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3256401-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3256401-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256398\" data-ts=\"1491839253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256398-endo-internationalplus-4-after-seeing-q1-revenue-in-line-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endo International +4% after seeing Q1 revenue in-line with estimates</a></h4><ul><li>Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+4.2%</font>) jumps 4% after <a href=\"https://seekingalpha.com/filing/3498632\" target=\"_blank\">pre-announcing Q1 results</a> with revenue in-line with estimates.</li><li>ENDP sees Q1 adjusted EBITDA of $440M-$460M, with revenues rising 5%-7% to $1.015B-$1.035B vs. $964M in the prior-year quarter and $1.02B analyst consensus; results include a $45M impairment for serelaxin after the drug's Phase 3 disappointment.</li><li>ENDP also reiterates that it is assessing strategic alternatives for its Grupo Farmac&eacute;utico Somar,  Sociedad An&oacute;nima Promotora de Inversi&oacute;n de Capital Variable business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256398\" data-linked=\"Endo International +4% after seeing Q1 revenue in-line with estimates\" data-tweet=\"$ENDP - Endo International +4% after seeing Q1 revenue in-line with estimates https://seekingalpha.com/news/3256398-endo-internationalplus-4-after-seeing-q1-revenue-in-line-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3256398-endo-internationalplus-4-after-seeing-q1-revenue-in-line-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256396\" data-ts=\"1491839048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMED\" target=\"_blank\">OMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256396-down-35-oncomed-defended-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Down 35%, Oncomed defended at Wells Fargo</a></h4><ul><li>With the share price nearing $5, after the Phase 2 trial for demcizumab missed its primary endpoint,&nbsp;Wells Fargo's Jim Birchenough sees limited downside.</li><li>With $5 per share in cash and a $4-$5 per share value for cancer stem cell therapeutics, Birchenough retains his Outperform rating, and sets a price target range of $9-$10 (down from $19-$25).</li><li>Source: <a href=\"http://thefly.com/landingPageNews.php?id=2532036&amp;headline=OMED-OncoMed-shares-have-limited-downside-says-Wells-Fargo\" target=\"_blank\">TheFly</a></li><li>OncoMed (NASDAQ:<a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a>) currently&nbsp;<font color='red'>down 34.8%</font>&nbsp;to $5.71.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256336-oncomed-misses-endpoint-clinical-trial-bayer-will-license-two-drugs\" target=\"_blank\">OncoMed misses endpoint on clinical trial; Bayer will not license two drugs</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3256396\" data-linked=\"Down 35%, Oncomed defended at Wells Fargo\" data-tweet=\"$OMED - Down 35%, Oncomed defended at Wells Fargo https://seekingalpha.com/news/3256396-down-35-oncomed-defended-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3256396-down-35-oncomed-defended-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256392\" data-ts=\"1491838065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETN\" target=\"_blank\">ETN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256392-eaton-cummins-form-jv-for-automated-transmissions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eaton, Cummins form JV for automated transmissions</a></h4><ul>     <li>Eaton (<a href='https://seekingalpha.com/symbol/ETN' title='Eaton Corp. plc'>ETN</a> <font color='green'>+2.1%</font>) and Cummins (<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color='green'>+0.8%</font>) are higher after disclosing a <a href=\"https://seekingalpha.com/filing/3498818\" target=\"_blank\">joint venture</a> for automated transmissions for heavy- and medium-duty commercial vehicles, to be named Eaton Cummins Automated Transmission Technologies.</li><li>CMI will pay $600M to ETN for a 50% stake in the JV to further integrate its engines with ETN's automated transmission  system in the North American truck market.</li>     <li>Stifel reiterates its Hold rating and $150 price target on CMI, saying the JV deal \"<a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Reiterates+Hold+Rating+and+$150+PT+on+Cummins+%28CMI%29%3B+Eaton+%28ETN%29+JV+Makes+Sense/12763211.html\" target=\"_blank\">makes sense</a>.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3256392\" data-linked=\"Eaton, Cummins form JV for automated transmissions\" data-tweet=\"$ETN $ETN $CMI - Eaton, Cummins form JV for automated transmissions https://seekingalpha.com/news/3256392-eaton-cummins-form-jv-for-automated-transmissions?source=tweet\" data-url=\"https://seekingalpha.com/news/3256392-eaton-cummins-form-jv-for-automated-transmissions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256373\" data-ts=\"1491836456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256373-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SSKN' title='STRATA Skin Sciences, Inc'>SSKN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256373\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PSTV $AXON-OLD $GERN - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3256373-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3256373-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256379\" data-ts=\"1491835035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256379-report-trump-weighs-potentially-explosive-steel-aluminum-import-tariffs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Trump weighs potentially explosive steel, aluminum import tariffs</a></h4><ul><li>AK&nbsp;Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-6.6%</font>) and other steel and aluminum producers (<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='red'>-0.3%</font>) are lower following a report that the Trump administration is considering \"<a href=\"https://www.axios.com/scoop-trumps-potentially-explosive-trade-play-2352691437.html\" target=\"_blank\">potentially explosive</a>\" steel and aluminum import tariffs.</li><li>Axios reports that the administration is working on an executive order that would  initiate investigations into \"unfair\" product dumping from foreign  companies, an action that could lead to tariffs on a wide range of  products.</li><li>Notable Calls opines that such action <a href=\"https://twitter.com/thenotablecalls/status/851401359794597889\" target=\"_blank\">could significantly boost</a> U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-1.1%</font>) and aluminum producers such as Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-0.9%</font>), as it would drive up pricing.</li><li>But sector shares now are broadly lower, including: <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='red'>-0.3%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-0.4%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-0.6%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-1.2%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-1.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256379\" data-linked=\"Report: Trump weighs potentially explosive steel, aluminum import tariffs\" data-tweet=\"$AKS $AKS $SLX - Report: Trump weighs potentially explosive steel, aluminum import tariffs https://seekingalpha.com/news/3256379-report-trump-weighs-potentially-explosive-steel-aluminum-import-tariffs?source=tweet\" data-url=\"https://seekingalpha.com/news/3256379-report-trump-weighs-potentially-explosive-steel-aluminum-import-tariffs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>138&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256376\" data-ts=\"1491834325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJM\" target=\"_blank\">SJM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256376-j-m-smucker-dips-after-morgan-stanley-warns-on-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.M. Smucker dips after Morgan Stanley warns on pricing</a></h4><ul> <li>Morgan Stanley cites <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/10/smucker-stuck-between-wal-mart-and-private-labels-is-a-sell/\" target=\"_blank\">pricing pressure</a> from Wal-Mart in lowering J.M. Smucker (<a href='https://seekingalpha.com/symbol/SJM' title='J. M. Smucker Company'>SJM</a> <font color='red'>-0.9%</font>) to an Underweight rating from Equal Weight.</li> <li>\"Walmart comprises ~22% of sales across our coverage, a figure that has increased in recent years even as the retailer&rsquo;s total grocery sales have grown at an even faster 4% CAGR. With Food margins expected to expand meaningfully, we believe this only enhances Walmart&rsquo;s negotiating leverage going forward. SJM, Dean Foods, and General Mills are most at risk in the current environment,\" warns MS.</li> <li>The firm slides its price target on SJM down to $126.</li> <li>Shares of J.M. Smucker are level from where they stood a year ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256376\" data-linked=\"J.M. Smucker dips after Morgan Stanley warns on pricing\" data-tweet=\"$SJM - J.M. Smucker dips after Morgan Stanley warns on pricing https://seekingalpha.com/news/3256376-j-m-smucker-dips-after-morgan-stanley-warns-on-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3256376-j-m-smucker-dips-after-morgan-stanley-warns-on-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256372\" data-ts=\"1491832947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JLL\" target=\"_blank\">JLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256372-jones-lang-lasalleplus-1_8-after-positive-barrons-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Lang LaSalle +1.8% after positive Barron&#39;s mention</a></h4><ul><li>It's been a tough run of late for Jones Lang LaSalle (NYSE:<a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang Lasalle Inc.'>JLL</a>),&nbsp;<font color='red'>down nearly 10%</font>&nbsp;Y/Y vs. the S&amp;P 500's&nbsp;<font color='green'>15% advance</font>.</li><li>Worries about the long-in-the-tooth commercial property cycle are likely baked into the share price, <a href=\"http://www.barrons.com/articles/jones-lang-lasalle-soon-to-be-a-hot-property-1491626045\" target=\"_blank\">writes David Englander</a>, and investors aren't giving <a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang Lasalle Inc.'>JLL</a> much credit for its less-cyclical, annuity-like operations like facility management and property project management services - which together account for more than 60% of annual revenue.</li><li>Shares&nbsp;<font color='green'>+1.8%</font>&nbsp;in early action today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256372\" data-linked=\"Jones Lang LaSalle +1.8% after positive Barron&#39;s mention\" data-tweet=\"$JLL - Jones Lang LaSalle +1.8% after positive Barron&#39;s mention https://seekingalpha.com/news/3256372-jones-lang-lasalleplus-1_8-after-positive-barrons-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3256372-jones-lang-lasalleplus-1_8-after-positive-barrons-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256370\" data-ts=\"1491832918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256370-fda-continues-partial-clinical-hold-for-repros-therapeutics-fibroids-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA continues partial clinical hold for Repros Therapeutics&#39; fibroids drug</a></h4><ul><li>Repros Therapeutics (<a href='https://seekingalpha.com/symbol/RPRX' title='Repros Therapeutics Inc.'>RPRX</a> <font color='green'>+7.2%</font>) discloses that the FDA will <a href=\"https://seekingalpha.com/pr/16795031-company-holds-meeting-fda-discuss-oral-proellex-treatment-uterine-fibroids\" target=\"_blank\">continue a partial clinical  hold</a> for the company's Proellex drug for uterine fibroids, or tumors in the uterus; shares resume trading after a halt began before the open.</li><li>RPRX says the FDA plans to consult with its liver experts about  the liver toxicity that has been previously experienced with the drug; RPRX expects to submit additional information  and a proposed clinical protocol within a month.</li><li>The FDA has previously put development programs for Proellex on clinical  holds because of safety concerns.</li><li>Also, RPRX names Larry Dillaha as its <a href=\"https://seekingalpha.com/pr/16795037-repros-names-larry-dillaha-m-d-permanent-president-ceo\" target=\"_blank\">full-time President and CEO</a> effective immediately, after serving in the positions on an interim basis since Feb. 1; Dillaha previously was CEO of inception stage biotech CavtheRx and COO and Chief Medical Officer of New Haven Pharmaceuticals.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256370\" data-linked=\"FDA continues partial clinical hold for Repros Therapeutics&#39; fibroids drug\" data-tweet=\"$RPRX - FDA continues partial clinical hold for Repros Therapeutics&#39; fibroids drug https://seekingalpha.com/news/3256370-fda-continues-partial-clinical-hold-for-repros-therapeutics-fibroids-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3256370-fda-continues-partial-clinical-hold-for-repros-therapeutics-fibroids-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256369\" data-ts=\"1491832880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256369-colossal-merger-shakes-up-trucking\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colossal merger shakes up trucking</a></h4><ul> <li>Swift Transportation (SWFT <font color='green'>+21.3%</font>) and Knight Transportation (<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color='green'>+11.7%</font>) rattled the trucking sector today with their plan to <a href=\"https://seekingalpha.com/news/3256307-swift-transportation-knight-transportation-merge\" target=\"_blank\">merge</a> into a new company called Knight-Swift Transportation Holdings.</li> <li>The new entity is expected to have an implied enterprise value of ~$6B and see accretive benefits immediately to EPS from shared costs.</li> <li>The executive team will be led by Kevin Knight as Executive Chairman and Dave Jackson as CEO, both from Knight Transportation.</li> <li>Aegis Capital thinks Knight is getting a good deal (46% of equity for 66% of the combined EBITDA).</li> <li>Trucking stocks are solidly higher on the day as investors gauge if more M&amp;A might come down the road. Celadon Group (<a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='green'>+9.3%</font>), USA Truck (<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='green'>+2.9%</font>), YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='green'>+2.8%</font>), Landstar System (<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a> <font color='green'>+1.7%</font>), J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='green'>+1.9%</font>) and Marten Transport (<a href='https://seekingalpha.com/symbol/MRTN' title='Marten Transport, Ltd.'>MRTN</a> <font color='green'>+2.4%</font>) are some of the notable movers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256369\" data-linked=\"Colossal merger shakes up trucking\" data-tweet=\"$KNX $KNX $CGI - Colossal merger shakes up trucking https://seekingalpha.com/news/3256369-colossal-merger-shakes-up-trucking?source=tweet\" data-url=\"https://seekingalpha.com/news/3256369-colossal-merger-shakes-up-trucking\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256366\" data-ts=\"1491832309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUN\" target=\"_blank\">SUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256366-sunoco-surges-on-three-upgrades-following-7-eleven-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco surges on three upgrades following 7-Eleven deal</a></h4><ul><li>Sunoco (<a href='https://seekingalpha.com/symbol/SUN' title='Sunoco LP'>SUN</a> <font color='green'>+1.9%</font>) jumps past $30 at the open, as three firms have upgraded shares following the <a href=\"https://seekingalpha.com/news/3255827-seven-and-buy-sunoco-assets-3_3b\" target=\"_blank\">$3.3B sale</a> of the majority of its real estate portfolio to 7-Eleven.</li><li>Baird <a href=\"http://www.marketwatch.com/story/sunoco-upgraded-to-outperform-after-convenience-store-divestiture-2017-04-10\" target=\"_blank\">upgrades</a> SUN to Outperform from Neutral with a  $36 price target, up from $28, as it now sees a &ldquo;reasonable path&rdquo; for SUN to cover its distribution; the firm also sees the deal as a precursor for SUN to &ldquo;move back into its parents basement\" - i.e., a roll-up of SUN into Energy Transfer Partners (ETP <font color='red'>-0.1%</font>).</li><li>Jefferies <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Jefferies+Upgrades+Sunoco+%28SUN%29+to+Hold/12761210.html\" target=\"_blank\">raises</a> shares to Hold from Underperform with a $29 target, up from $20, saying SUN should be able to delever and execute a significant unit buyback but still struggles to see how SUN achieves 4.5x-4.75x leverage and 1.1x coverage targets without &ldquo;additional measures.\"</li><li><a href=\"https://seekingalpha.com/news/3256192-sunoco-upgraded-barclays-sees-gains-c-store-sale\" target=\"_blank\">On Friday</a>, Barclays upgraded SUN to Overweight from Equal Weight with a $35 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256366\" data-linked=\"Sunoco surges on three upgrades following 7-Eleven deal\" data-tweet=\"$SUN $SUN $ET - Sunoco surges on three upgrades following 7-Eleven deal https://seekingalpha.com/news/3256366-sunoco-surges-on-three-upgrades-following-7-eleven-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3256366-sunoco-surges-on-three-upgrades-following-7-eleven-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256360\" data-ts=\"1491831486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256360-gemphire-therapeutics-flies-after-piper-launches-favorable-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gemphire Therapeutics flies after Piper launches favorable coverage</a></h4><ul> <li>Piper Jaffray initiates coverage on Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) with an Overweight rating on a very positive long term view of the biopharma name.</li> <li>The firm sets a price target of $30, which is almost triple the closing price of Gemphire on Friday. Shares are&nbsp;<font color='green'>up 9.55%</font>&nbsp;in ealy trading after the confidence boost from Piper.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3256360\" data-linked=\"Gemphire Therapeutics flies after Piper launches favorable coverage\" data-tweet=\"$GEMP - Gemphire Therapeutics flies after Piper launches favorable coverage https://seekingalpha.com/news/3256360-gemphire-therapeutics-flies-after-piper-launches-favorable-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3256360-gemphire-therapeutics-flies-after-piper-launches-favorable-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256352\" data-ts=\"1491830852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256352-globalstar-up-15-in-wake-of-and-t-straight-path-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar up 15% in wake of AT&amp;T-Straight Path deal</a></h4><ul>   <li>Following a big deal this morning bringing together a telecom giant with a millimeter-wave spectrum holder -- AT&amp;T's <a href=\"https://seekingalpha.com/news/3256334-t-buying-straight-path-communications-whopping-1_6b\" target=\"_blank\">$1.6B deal for Straight Path Communications</a> -- Globalstar (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a>) is <font color='green'>up 15.4%</font> to what would be its highest point since June.</li>    <li>The company -- which is banking on its Terrestrial Low-Power Service to tap unlicensed spectrum for Wi-Fi networking -- <a href=\"https://seekingalpha.com/news/3187178-globalstar-tanks-minus-51-percent-chatter-fcc-vote\" target=\"_blank\">slid last June</a> after chatter that the company was headed for a no-vote on the company's frequency use. It <a href=\"https://seekingalpha.com/news/3231388-globalstar-plus-29-percent-fcc-circulates-revised-proposal\" target=\"_blank\">rebounded in December</a> after a revised FCC proposal.</li>    <li>Shorts could see a squeeze here. There were more than 94M shares short; short percentage of float sat at 23.3%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256352\" data-linked=\"Globalstar up 15% in wake of AT&amp;T-Straight Path deal\" data-tweet=\"$GSAT - Globalstar up 15% in wake of AT&amp;T-Straight Path deal https://seekingalpha.com/news/3256352-globalstar-up-15-in-wake-of-and-t-straight-path-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3256352-globalstar-up-15-in-wake-of-and-t-straight-path-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256351\" data-ts=\"1491830802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256351-therapeuticsmd-provides-txminus-004hr-regulatory-update-shares-down-20-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD provides TX-004HR regulatory update; shares down 20% premarket</a></h4><ul> <li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) <a href=\"https://seekingalpha.com/pr/16794709-therapeuticsmd-provides-txminus-004hr-regulatory-update\" target=\"_blank\">announces</a> that the Company received a       letter from the FDA stating that, as       part of the FDA&rsquo;s ongoing review of the Company&rsquo;s new drug application &#40;NDA&#41; for <a href=\"https://www.therapeuticsmd.com/research/tx004hr\" target=\"_blank\">TX-004HR</a>, an applicator-free vaginal estradiol       softgel drug candidate for the treatment of moderate to severe       <a href=\"https://en.wikipedia.org/wiki/Dyspareunia\" target=\"_blank\">dyspareunia</a>, the FDA has       identified deficiencies that preclude discussion of labeling and       postmarketing requirements/commitments at this time.</li>          <li>The FDA previously set a target action date under the Prescription Drug       User Fee Act &#40;PDUFA&#41; of May 7 to complete the FDA&rsquo;s review of the       NDA.</li><li>Shares are down&nbsp;<font color='red'>20%</font>&nbsp;premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3256351\" data-linked=\"TherapeuticsMD provides TX-004HR regulatory update; shares down 20% premarket\" data-tweet=\"$TXMD - TherapeuticsMD provides TX-004HR regulatory update; shares down 20% premarket https://seekingalpha.com/news/3256351-therapeuticsmd-provides-txminus-004hr-regulatory-update-shares-down-20-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3256351-therapeuticsmd-provides-txminus-004hr-regulatory-update-shares-down-20-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256349\" data-ts=\"1491830309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256349-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+151%&nbsp;</font>on being <a href=\"https://seekingalpha.com/pr/16794804-t-enters-definitive-agreement-acquire-straight-path-communications-95_63-per-share-stock-deal\" target=\"_blank\">acquired</a> by AT&amp;T.</li><li><a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='green'>+34%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794620-cytori-receives-u-s-fda-approval-burn-clinical-trial-related-barda-contract\" target=\"_blank\">receiving</a> U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract.</li><li><a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+21%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16794671-geron-announces-completion-second-internal-data-reviews-imetelstat-trials-conducted-janssen\" target=\"_blank\">announcing</a> completion of second internal data reviews for Imetelstat trials being conducted by Janssen.</li><li><a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+19%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794793-axovant-sciences-announces-appointment-dr-david-hung-chief-executive-officer-expansion-board\" target=\"_blank\">announcing</a> appointment of Dr. David Hung as CEO and Expansion of Board of Directors.</li><li>SWFT <font color='green'>+19%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794647-swift-transportation-announces-anticipated-range-first-quarter-2017-earnings\" target=\"_blank\">announcing</a> guidance for 1Q17.</li><li><a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='green'>+15%</font></li><li><a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='green'>+15%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/16794874-cemtrex-receives-multi-million-dollar-order-new-customer\" target=\"_blank\">receiving</a>&nbsp;Multi-million Dollar Order From New Customer.</li><li><a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/symbol/XCRA' title='Xcerra Corporation'>XCRA</a> <font color='green'>+10%</font>&nbsp;on being <a href=\"https://seekingalpha.com/pr/16794627-xcerra-corporation-acquired-approximately-580m-unic-capital-management-co-ltd-affiliate-sino\" target=\"_blank\">acquired</a> for approx.$580M by Unic Capital Management Co., Ltd, an Affiliate of Sino IC Capital.</li><li><a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='green'>+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256349\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$STRP $PSTV $GERN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3256349-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3256349-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256348\" data-ts=\"1491830137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256348-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-42%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794737-oncomed-s-phase-2-demcizumab-pancreatic-cancer-trial-misses-primary-endpoint\" target=\"_blank\">missing</a> clinical trial endpoint.</li><li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='red'>-22%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794709-therapeuticsmd-provides-txminus-004hr-regulatory-update\" target=\"_blank\">providing</a> update on TX-004HR.</li><li><a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-20%</font>.</li><li><a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16794766-intellipharmaceutics-announces-patent-litigation-purdue-rexista-abuse-deterrent-extended\" target=\"_blank\">announcing</a> patent litigation by Purdue against Rexista.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3256348\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$OMED $TXMD $OPTT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3256348-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3256348-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256342\" data-ts=\"1491829374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256342-susquehanna-sees-fair-value-on-skechers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna sees fair value on Skechers</a></h4><ul> <li>Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) is on watch after Susquehanna <a href=\"https://www.streetinsider.com/Analyst+Comments/Susquehanna+Upgrades+Skechers+USA+%28SKX%29+to+Neutral%3B+Fairly+Valued+Amid+Drop/12761789.html\" target=\"_blank\">upgrades</a> the shoe seller to Neutral after having it slotted with a Negative rating.</li> <li>The firm pulls its bearish call on Skechers with pressure in the U.S. wholesale business now reflected in share price (13X PE).</li> <li>SKX <font color='green'>+1.21%</font> premarket to $25.15 vs. the $25 price target from Susquehanna.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3256342\" data-linked=\"Susquehanna sees fair value on Skechers\" data-tweet=\"$SKX - Susquehanna sees fair value on Skechers https://seekingalpha.com/news/3256342-susquehanna-sees-fair-value-on-skechers?source=tweet\" data-url=\"https://seekingalpha.com/news/3256342-susquehanna-sees-fair-value-on-skechers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256340\" data-ts=\"1491828792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLS\" target=\"_blank\">SPLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256340-staples-on-move-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Staples on the move again</a></h4><ul> <li>Shares of Staples (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLS' title='Staples, Inc.'>SPLS</a>) are moving higher in premarket trading again after the retailer was mentioned favorably in Barron's last week.</li> <li>A large shareholder told the publication that the fair value of the stock is <a href=\"http://www.barrons.com/articles/lbo-or-not-staples-stock-looks-very-undervalued-1491413854\" target=\"_blank\">$15</a>, suggesting almost more than 50% upside from Friday's closing price.</li> <li>SPLS <font color='green'>+2.56%</font> premarket to $10.00.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3256340\" data-linked=\"Staples on the move again\" data-tweet=\"$SPLS - Staples on the move again https://seekingalpha.com/news/3256340-staples-on-move-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3256340-staples-on-move-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256334\" data-ts=\"1491827807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256334-t-buying-straight-path-communications-for-whopping-1_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T buying Straight Path Communications for a whopping $1.6B</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16794804-t-enters-definitive-agreement-acquire-straight-path-communications-95_63-per-share-stock-deal\" target=\"_blank\">The all-stock deal </a>which is intended to qualify as a tax-free reorganization works out to $95.63 per Straight Path (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) share, a&nbsp;<font color='green'>162% premium</font>&nbsp;to Friday's close (and<font color='green'> triple the price&nbsp;</font>from Jan. 11 when STRP announced 'strategic alternatives' process).</li><li>The amount of AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) stock will be adjusted to ensure consideration of $95.63 per share.</li><li>Straight Path was spun into an independent company in 2013 at a price of $6.40 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256334\" data-linked=\"AT&amp;T buying Straight Path Communications for a whopping $1.6B\" data-tweet=\"$STRP $STRP $T - AT&amp;T buying Straight Path Communications for a whopping $1.6B https://seekingalpha.com/news/3256334-t-buying-straight-path-communications-for-whopping-1_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3256334-t-buying-straight-path-communications-for-whopping-1_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256332\" data-ts=\"1491827291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XCO\" target=\"_blank\">XCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256332-exco-resources-to-sell-south-texas-oil-and-gas-properties-for-300m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exco Resources to sell south Texas oil and gas properties for $300M</a></h4><ul>     <li>Exco Resources (NYSE:<a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a>) <font color='green'>+19.3%</font> premarket after <a href=\"https://seekingalpha.com/pr/16794698-exco-resources-executes-agreement-divest-south-texas-oil-natural-gas-properties\" target=\"_blank\">agreeing to sell</a> its oil and natural gas properties in south Texas for $300M to Venado Oil &amp;&nbsp;Gas.</li>     <li>XCO says the properties produced ~4,100 boe/day (~90% oil) during December 2016.</li><li>XCO says it plans to focus on drilling and development of its  core Haynesville  and Bossier  shale assets in north  Louisiana and east  Texas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256332\" data-linked=\"Exco Resources to sell south Texas oil and gas properties for $300M\" data-tweet=\"$XCO - Exco Resources to sell south Texas oil and gas properties for $300M https://seekingalpha.com/news/3256332-exco-resources-to-sell-south-texas-oil-and-gas-properties-for-300m?source=tweet\" data-url=\"https://seekingalpha.com/news/3256332-exco-resources-to-sell-south-texas-oil-and-gas-properties-for-300m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256326\" data-ts=\"1491826537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GERN\" target=\"_blank\">GERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256326-geron-completes-second-internal-data-reviews-for-imetelstat-trials-shares-ahead-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron completes second internal data reviews for Imetelstat trials; shares ahead 16% premarket</a></h4><ul> <li>Geron Corporation (<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/16794671-geron-announces-completion-second-internal-data-reviews-imetelstat-trials-conducted-janssen\" target=\"_blank\">announces</a> that Janssen Research &amp; Development, LLC has completed the second internal data reviews of <a href=\"http://www.geron.com/patients/imerge-study/\" target=\"_blank\">IMerge</a> and <a href=\"http://www.geron.com/patients/imbark-study/\" target=\"_blank\">IMbark</a>, the clinical trials of the telomerase inhibitor <a href=\"http://www.geron.com/r-d/imetelstat/\" target=\"_blank\">imetelstat</a> in lower risk <a href=\"https://en.wikipedia.org/wiki/Myelodysplastic_syndrome\" target=\"_blank\">myelodysplastic syndromes</a> &#40;MDS&#41; and relapsed or refractory <a href=\"https://medlineplus.gov/ency/article/000531.htm\" target=\"_blank\">myelofibrosis</a> &#40;MF&#41;, respectively.</li>    <li>For IMerge, the benefit/risk profile of imetelstat in the treated patients supports continued development in MDS. A data package and proposed trial design refinements are planned to be provided to the FDA.</li><li>For IMbark, the current results suggest clinical benefit and a potential overall survival benefit associated with imetelstat treatment in MF; the trial will continue unchanged to evaluate maturing efficacy and safety data, including an assessment of overall survival.</li>        <li>IMerge (NCT02598661) is a Phase 2/3 clinical trial evaluating imetelstat in transfusion dependent patients with Low or Intermediate-1 risk MDS who have relapsed after or are refractory to prior treatment with an erythropoiesis stimulating agent &#40;ESA&#41;. The clinical trial is in two parts: Part 1 is a Phase 2, open-label, single-arm design in ~30 patients and Part 2 is designed to be a Phase 3, randomized, controlled trial in ~170 patients. The primary efficacy endpoint is the rate of red blood cell transfusion independence lasting at least 8 weeks. Key secondary endpoints include the rates of red blood cell transfusion independence lasting at least 24 weeks and hematologic improvement. Part 1 of the trial is fully enrolled.</li>                <li>IMbark (NCT02426086) was originally designed as a Phase 2 clinical trial to evaluate two dose levels of imetelstat (either 4.7 mg/kg or 9.4 mg/kg administered every three weeks) in ~200 patients with Intermediate-2 or High risk MF. The co-primary efficacy endpoints for the trial are spleen response rate (&ge;35% reduction of spleen volume assessed by imaging) and symptom response rate (50% reduction in Total Symptom Score) at 24 weeks.</li>    <li>The second internal review of IMbark included data from the ~100 patients who were enrolled in the trial, with each dosing arm analyzed separately.</li>    <li>During the next year, Geron expects Janssen to evaluate maturing efficacy and safety data from the trial, including an assessment of overall survival.</li><li>Shares are up&nbsp;<font color='green'>16%</font>&nbsp;premarket.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3256326\" data-linked=\"Geron completes second internal data reviews for Imetelstat trials; shares ahead 16% premarket\" data-tweet=\"$GERN - Geron completes second internal data reviews for Imetelstat trials; shares ahead 16% premarket https://seekingalpha.com/news/3256326-geron-completes-second-internal-data-reviews-for-imetelstat-trials-shares-ahead-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3256326-geron-completes-second-internal-data-reviews-for-imetelstat-trials-shares-ahead-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>253&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256320\" data-ts=\"1491825488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBR\" target=\"_blank\">CBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256320-ciber-files-for-chapter-11-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciber files for Chapter 11 bankruptcy</a></h4><ul>     <li>Ciber (NYSE:<a href='https://seekingalpha.com/symbol/CBR' title='CIBER, Inc.'>CBR</a>) <a href=\"https://seekingalpha.com/pr/16794513-ciber-files-chapter-11-protection-secures-45-million-dip-financing-fund-ongoing-operations\" target=\"_blank\">files for Chapter 11</a> bankruptcy protection, also saying it has a commitment for up to $45M in DIP financing, subject to court approval, which it expects to provide liquidity to maintain U.S. operations.</li>     <li>Prior to the filing, CBR says it entered into a \"stalking horse\" agreement with Capgemini for the purchase of all company assets in North America and India for $50M.</li>     <li>CBR lists assets in the $50M-$100M range, with liabilities in a similar range.</li><li>CBR <font color='red'>-19.3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256320\" data-linked=\"Ciber files for Chapter 11 bankruptcy\" data-tweet=\"$CBR - Ciber files for Chapter 11 bankruptcy https://seekingalpha.com/news/3256320-ciber-files-for-chapter-11-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3256320-ciber-files-for-chapter-11-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256319\" data-ts=\"1491825476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256319-cypress-semi-1_3-suntrust-buys-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress Semi + 1.3% as SunTrust buys the dip</a></h4><ul><li>The stock's had a nice run higher, but has&nbsp;<font color='red'>dipped nearly 10%</font>&nbsp;in the last couple of weeks, with analyst William Stein attributing that to no positive pre-announcement and confusing gross margin commentary at analyst day.</li><li>Stein still sees a Q2 beat and higher operating margins.</li><li>He upgrades to Buy from Hold with $17 price target suggesting&nbsp;<font color='green'>25% upside</font>.</li><li><a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a>&nbsp;<font color='green'>+1.3%</font>&nbsp;premarket to $13.77.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256319\" data-linked=\"Cypress Semi + 1.3% as SunTrust buys the dip\" data-tweet=\"$CY - Cypress Semi + 1.3% as SunTrust buys the dip https://seekingalpha.com/news/3256319-cypress-semi-1_3-suntrust-buys-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3256319-cypress-semi-1_3-suntrust-buys-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256315\" data-ts=\"1491824645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256315-bhp-billitonplus-3-elliott-urges-spinoff-of-oil-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP Billiton +3% as Elliott urges spinoff of oil business</a></h4><ul>     <li>BHP&nbsp;Billiton (NYSE:<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a>)&nbsp;<font color='green'>+3.2%</font> premarket after activist investor Elliott Management <a href=\"http://www.marketwatch.com/story/bhp-billiton-urged-by-elliott-to-spin-off-assets-2017-04-10\" target=\"_blank\">targets the company</a>, urging it to spin off its U.S. petroleum assets and unify its dual U.K.-Australia structure.</li>     <li>Elliott, which says it owns a 4.1% stake in BHP, says its plan would enable BHP's management to provide shareholders with an increase in value of up to ~49% on the Australia-listed shares and 51% on the U.K.-listed shares.</li>     <li>\"Despite being a leading global resources company with a portfolio of best-in-class large-scale diversified mining assets, in recent years BHP as an investment has underperformed a portfolio of comparable mineral and petroleum companies,\" Elliott Management says in a <a href=\"https://seekingalpha.com/pr/16794506-elliott-sends-letter-presentation-directors-bhp-billiton-outlining-shareholder-value-unlock\" target=\"_blank\">letter to BHP's board</a>.</li>     <li>In a <a href=\"http://www.bhpbilliton.com/media-and-insights/news-releases/2017/04/bhp-billiton-notes-elliott-proposal\" target=\"_blank\">response</a>, BHP says the costs and risks of Elliott's proposal would significantly outweigh any potential benefits.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256315\" data-linked=\"BHP Billiton +3% as Elliott urges spinoff of oil business\" data-tweet=\"$BHP - BHP Billiton +3% as Elliott urges spinoff of oil business https://seekingalpha.com/news/3256315-bhp-billitonplus-3-elliott-urges-spinoff-of-oil-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3256315-bhp-billitonplus-3-elliott-urges-spinoff-of-oil-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256311\" data-ts=\"1491824047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256311-fda-approves-cytoris-burn-clinical-trial-related-to-barda-contract-shares-ahead-23-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA approves Cytori&#39;s burn clinical trial related to BARDA contract; shares ahead 23% premarket</a></h4><ul> <li>Cytori Therapeutics (<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a>) <a href=\"https://seekingalpha.com/pr/16794620-cytori-receives-u-s-fda-approval-burn-clinical-trial-related-barda-contract\" target=\"_blank\">announces</a> that the FDA has approved an <a href=\"https://en.wikipedia.org/wiki/Investigational_device_exemption\" target=\"_blank\">Investigational Device Exemption</a> &#40;IDE&#41; for a pilot clinical trial to evaluate <a href=\"http://www.cytori.com/our-technology/cytori-cell-therapy/\" target=\"_blank\">Cytori Cell Therapy</a> in patients with thermal burn injury.</li><li>This trial, named the RELIEF trial, is a continuation of Cytori&rsquo;s ongoing R&amp;D efforts under its contract with the Biomedical Advanced Research&nbsp;and Development Authority &#40;BARDA&#41;, a division of the&nbsp;U.S. Department of Health and Human Services.</li>   <li>The RELIEF trial will assess safety and feasibility of intravenous delivery of Cytori Cell Therapy in patients with thermal burn injuries covering between 20% and 50% of their body surface area. The trial is approved to enroll up to 30 patients in up to 10 U.S. sites. Initiation of RELIEF is dependent upon execution of a contract option by BARDA to provide the necessary funds.</li><li>Shares are up&nbsp;<font color='green'>23%</font>&nbsp;premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3256311\" data-linked=\"FDA approves Cytori&#39;s burn clinical trial related to BARDA contract; shares ahead 23% premarket\" data-tweet=\"$CYTX $PSTV - FDA approves Cytori&#39;s burn clinical trial related to BARDA contract; shares ahead 23% premarket https://seekingalpha.com/news/3256311-fda-approves-cytoris-burn-clinical-trial-related-to-barda-contract-shares-ahead-23-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3256311-fda-approves-cytoris-burn-clinical-trial-related-to-barda-contract-shares-ahead-23-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256307\" data-ts=\"1491823311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256307-swift-transportation-knight-transportation-to-merge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Swift Transportation, Knight Transportation to merge</a></h4><ul>     <li>Swift Transportation (SWFT) and Knight Transportation (NYSE:<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a>) agree to a <a href=\"https://seekingalpha.com/pr/16794617-knight-transportation-swift-transportation-announce-stock-transaction-combined-enterprise\" target=\"_blank\">merger</a> in an all-stock transaction that will create the industry's largest full truckload company, with more than $5B in annual revenue.</li><li>The combined entity will be called Knight-Swift Transportation Holdings and will be headquartered in Phoenix; it will trade under the KNX ticker.</li><li>Each SWFT share will convert into 0.72 shares of Knight-Swift via  a reverse split, and each share of KNX to be exchanged for one  Knight-Swift share; SWFT shareholders will own ~54% and KNX shareholders will own ~46% of the combined company.</li><li>SWFT&nbsp;<font color='green'>+5.9%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256307\" data-linked=\"Swift Transportation, Knight Transportation to merge\" data-tweet=\"$KNX - Swift Transportation, Knight Transportation to merge https://seekingalpha.com/news/3256307-swift-transportation-knight-transportation-to-merge?source=tweet\" data-url=\"https://seekingalpha.com/news/3256307-swift-transportation-knight-transportation-to-merge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256302\" data-ts=\"1491822464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOW\" target=\"_blank\">SNOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256302-intrawest-resorts-sold-for-23_75-per-share-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intrawest Resorts sold for $23.75 per share; down 6% premarket</a></h4><ul><li>A newly formed entity controlled by Aspen Skiing Company and KSL Capital Partners is the buyer <a href=\"https://seekingalpha.com/pr/16794569-intrawest-resorts-holdings-inc-acquired-affiliates-aspen-skiing-company-ksl-capital-partners\" target=\"_blank\">in the all-cash deal</a>, which values <a href='https://seekingalpha.com/symbol/SNOW' title='Intrawest Resorts Holdings, Inc.'>SNOW</a> at about $1.5B, including debt. The deal is expected to close by the end of Q3.</li><li>While $23.75 is below Friday's close of $25.30, it's&nbsp;<font color='green'>40% more</font>&nbsp;than the price in mid-January when reports Intrawest was on the block first hit.</li><li>Shares<font color='red'> -6.6%</font>&nbsp;premarket to $23.63.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256302\" data-linked=\"Intrawest Resorts sold for $23.75 per share; down 6% premarket\" data-tweet=\"$SNOW - Intrawest Resorts sold for $23.75 per share; down 6% premarket https://seekingalpha.com/news/3256302-intrawest-resorts-sold-for-23_75-per-share-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3256302-intrawest-resorts-sold-for-23_75-per-share-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":52,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}